Financier | Commitments |
---|---|
Freestanding Tfs - Health, Nutrition & Population GP | 3.53 |
IDA Credit | 100.00 |
Pandemic Emergency Financing Facility | 2.90 |
P173820
Active
Jane Chuma , Toni Kuguru
Republic of Kenya
March 24, 2020
(as of board presentation)
April 2, 2020
April 8, 2020
US$ 50.00 million
Ministry of Health
2020
US$ 106.43 million
N/A
February 23, 2024
March 31, 2025
BANK APPROVED
Financier | Commitments |
---|---|
Freestanding Tfs - Health, Nutrition & Population GP | 3.53 |
IDA Credit | 100.00 |
Pandemic Emergency Financing Facility | 2.90 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 100.00 |
IBRD + IDA Commitment | 100.00 |
Lending Instrument | |
---|---|
Grant Amount | 6.43 |
Total Project Cost** | 50.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Oct 17, 2022 | IDA-65980 | Loan Disb | 36,234.34 |
Jan 3, 2022 | IDA-65980 | Loan Disb | 48,943.20 |
Dec 30, 2021 | IDA-65980 | Loan Disb | 59,664.80 |
Sep 9, 2022 | IDA-65980 | Loan Disb | 57,393.35 |
Sep 9, 2022 | IDA-65980 | Loan Disb | 80,855.77 |
Feb 7, 2022 | IDA-65980 | Loan Disb | 200,816.69 |
Oct 19, 2022 | IDA-65980 | Loan Disb | 15,185.89 |
Jun 24, 2022 | IDA-65980 | Loan Disb | 21,503.22 |
Jun 24, 2022 | IDA-65980 | Loan Disb | 30,144.70 |
Jun 30, 2022 | IDA-68230 | Loan Disb | 20,800,000.00 |
May 26, 2022 | IDA-65980 | Loan Disb | 63,795.76 |
Apr 1, 2022 | IDA-65980 | Loan Disb | 32,285.06 |
May 15, 2022 | IDA-65980 | Int Charges | 4,297.95 |
May 15, 2022 | IDA-65980 | Int Charges | 123,916.20 |
May 15, 2022 | IDA-65980 | Int Charges | 123,916.20 |
May 15, 2022 | IDA-65980 | Int Charges | 74,305.27 |
May 24, 2022 | IDA-65980 | Loan Disb | 35,165.23 |
Jul 12, 2022 | IDA-65980 | Loan Disb | 17,374.58 |
Jul 15, 2022 | IDA-69600 | Loan Disb | 3,315,066.50 |
Mar 3, 2022 | IDA-65980 | Loan Disb | 58,965.38 |
Oct 28, 2021 | IDA-65980 | Loan Disb | 5,058,204.00 |
Nov 15, 2021 | IDA-65980 | Int Charges | 1,017.55 |
Nov 15, 2021 | IDA-65980 | Int Charges | 110,512.44 |
Nov 15, 2021 | IDA-65980 | Int Charges | 110,512.44 |
Sep 23, 2021 | IDA-65980 | Loan Disb | 512,344.03 |
Nov 15, 2021 | IDA-65980 | Int Charges | 61,569.73 |
Jun 14, 2021 | IDA-65980 | Loan Disb | 178,882.83 |
Jan 21, 2021 | IDA-68230 | Loan Commitment | 50,000,000.00 |
Jun 28, 2021 | IDA-69600 | Loan Commitment | 130,000,000.00 |
Apr 2, 2020 | IDA-65980 | Loan Commitment | 50,000,000.00 |
Jun 7, 2024 | IDA-65980 | Loan Disb | 56,452.35 |
May 15, 2024 | IDA-65980 | Int Charges | 570.89 |
May 15, 2024 | IDA-65980 | Int Charges | 134,346.86 |
May 15, 2024 | IDA-65980 | Int Charges | 134,346.86 |
Jul 15, 2024 | IDA-68230 | Int Charges | 81,825.00 |
Jul 15, 2024 | IDA-68230 | Int Charges | 81,825.00 |
Apr 18, 2024 | IDA-65980 | Loan Disb | 108,664.71 |
Apr 15, 2024 | IDA-69600 | Int Charges | 7,839.18 |
Apr 5, 2024 | IDA-65980 | Loan Disb | 63,321.91 |
Feb 23, 2024 | IDA-65980 | Loan Disb | 71,039.65 |
Feb 22, 2022 | IDA-69600 | Loan Disb | 7,388,787.50 |
Nov 2, 2021 | IDA-65980 | Loan Disb | 938,199.10 |
Sep 14, 2021 | IDA-65980 | Loan Disb | 27,922.82 |
Oct 26, 2021 | IDA-65980 | Loan Disb | 944,107.10 |
Nov 5, 2021 | IDA-65980 | Loan Disb | 156,065.20 |
Nov 17, 2020 | IDA-65980 | Int Charges | 11,382.12 |
Nov 17, 2020 | IDA-65980 | Int Charges | 11,382.12 |
Nov 17, 2020 | IDA-65980 | Int Charges | 6,829.28 |
Nov 17, 2020 | IDA-65980 | Int Charges | 94,121.04 |
Nov 17, 2020 | IDA-65980 | Int Charges | 94,121.04 |
Nov 17, 2020 | IDA-65980 | Int Charges | 56,472.62 |
May 15, 2021 | IDA-65980 | Int Charges | 107,140.76 |
May 15, 2021 | IDA-65980 | Int Charges | 107,140.76 |
May 15, 2021 | IDA-65980 | Int Charges | 63,207.96 |
Apr 6, 2021 | IDA-65980 | Loan Disb | 116,483.12 |
Apr 6, 2021 | IDA-65980 | Loan Disb | 447,150.66 |
Apr 6, 2021 | IDA-65980 | Loan Disb | 96,444.26 |
Apr 6, 2021 | IDA-65980 | Loan Disb | 122,483.52 |
Apr 6, 2021 | IDA-65980 | Loan Disb | 24,609.11 |
Apr 22, 2020 | IDA-65980 | Loan Disb | 21,742,000.00 |
Jun 22, 2020 | IDA-65980 | Loan Disb | 1,598,432.10 |
Jan 6, 2021 | IDA-65980 | Loan Disb | 3,461,021.20 |
Oct 15, 2023 | IDA-69600 | Int Charges | 7,736.94 |
Oct 15, 2023 | IDA-69600 | Int Charges | 38,684.66 |
Oct 15, 2023 | IDA-69600 | Int Charges | 38,684.66 |
Oct 15, 2022 | IDA-69600 | Int Charges | 7,000.04 |
Nov 15, 2022 | IDA-65980 | Int Charges | 44.55 |
Nov 15, 2022 | IDA-65980 | Int Charges | 125,770.71 |
Nov 15, 2022 | IDA-65980 | Int Charges | 125,770.71 |
Nov 15, 2022 | IDA-65980 | Int Charges | 75,268.14 |
Nov 17, 2022 | IDA-65980 | Loan Disb | 18,436.16 |
Nov 17, 2022 | IDA-65980 | Loan Disb | 28,092.89 |
Oct 15, 2022 | IDA-69600 | Int Charges | 7,000.04 |
Oct 15, 2022 | IDA-69600 | Int Charges | 1,400.01 |
Oct 15, 2022 | IDA-69600 | Int Charges | 29,789.29 |
Oct 15, 2022 | IDA-69600 | Int Charges | 29,789.29 |
Sep 12, 2022 | IDA-65980 | Loan Disb | 23,332.39 |
Sep 12, 2022 | IDA-65980 | Loan Disb | 13,586.66 |
Oct 15, 2022 | IDA-69600 | Int Charges | 5,957.87 |
Apr 15, 2023 | IDA-69600 | Int Charges | 40,672.59 |
Apr 15, 2023 | IDA-69600 | Int Charges | 40,672.59 |
Apr 15, 2023 | IDA-69600 | Int Charges | 8,134.52 |
Jan 15, 2023 | IDA-68230 | Int Charges | 1,982.20 |
Jan 15, 2023 | IDA-68230 | Int Charges | 23,786.42 |
Mar 1, 2022 | IDA-65980 | Loan Disb | 22,063.21 |
Mar 1, 2022 | IDA-65980 | Loan Disb | 24,704.67 |
Dec 30, 2021 | IDA-65980 | Loan Disb | -59,044.51 |
Oct 17, 2022 | IDA-65980 | Loan Disb | 12,537.22 |
Oct 17, 2022 | IDA-65980 | Loan Disb | 119,350.39 |
Oct 17, 2022 | IDA-65980 | Loan Disb | 12,742.91 |
Jan 15, 2024 | IDA-68230 | Int Charges | 82,091.25 |
Jan 15, 2024 | IDA-68230 | Int Charges | 82,091.25 |
Jan 15, 2024 | IDA-68230 | Int Charges | 24,080.12 |
May 15, 2024 | IDA-65980 | Int Charges | 80,277.54 |
Apr 24, 2024 | IDA-65980 | Loan Disb | 207,404.12 |
Jul 15, 2024 | IDA-68230 | Int Charges | 24,002.02 |
Nov 15, 2023 | IDA-65980 | Int Charges | 133,207.25 |
Dec 15, 2023 | IDA-65980 | Loan Disb | 57,947.23 |
Nov 15, 2023 | IDA-65980 | Int Charges | 133,207.25 |
Nov 15, 2023 | IDA-65980 | Int Charges | 79,351.32 |
Jan 10, 2024 | IDA-65980 | Loan Disb | 30,227.19 |
Apr 15, 2024 | IDA-69600 | Int Charges | 39,195.89 |
Apr 15, 2024 | IDA-69600 | Int Charges | 39,195.89 |
May 15, 2023 | IDA-65980 | Int Charges | 203.01 |
May 15, 2023 | IDA-65980 | Int Charges | 132,831.06 |
May 15, 2023 | IDA-65980 | Int Charges | 132,831.06 |
May 15, 2023 | IDA-65980 | Int Charges | 79,698.66 |
Aug 25, 2023 | IDA-65980 | Loan Disb | 107,865.14 |
Sep 21, 2023 | IDA-65980 | Loan Disb | 136,033.05 |
Sep 21, 2023 | IDA-65980 | Loan Disb | 51,361.93 |
Sep 21, 2023 | IDA-65980 | Loan Disb | 16,787.63 |
Sep 21, 2023 | IDA-65980 | Loan Disb | 76,538.05 |
Sep 21, 2023 | IDA-65980 | Loan Disb | 31,344.58 |
Jan 15, 2023 | IDA-68230 | Int Charges | 6,757.50 |
Jan 15, 2023 | IDA-68230 | Int Charges | 6,757.50 |
Jan 15, 2023 | IDA-68230 | Int Charges | 81,090.00 |
Jan 15, 2023 | IDA-68230 | Int Charges | 81,090.00 |
Jul 15, 2023 | IDA-68230 | Int Charges | 84,150.00 |
Jul 15, 2023 | IDA-68230 | Int Charges | 84,150.00 |
Jul 15, 2023 | IDA-68230 | Int Charges | 24,684.02 |
Name | Review | Date |
---|---|---|
Project Management | Moderately Satisfactory | 2024-08-14 |
Monitoring and Evaluation | Satisfactory | 2024-08-14 |
Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-08-14 |
Procurement | Moderately Satisfactory | 2024-08-14 |
Progress towards achievement of PDO | Satisfactory | 2024-08-14 |
Financial Management | Moderately Satisfactory | 2024-08-14 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Percentage of suspected cases of COVID-19 cases reported and investigated based on national guidelines | Value | 0.00 | 100.00 | 80.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents | Value | 2.00 | 31.00 | 24.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of people who know at least 3 measures to prevent COVID-19 | Value | 0.00 | 84.00 | 80.00 |
Date | September 25, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of safe blood available for transfusion in the country | Value | 22.00 | 70.70 | 80.00 |
Date | September 18, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of population fully vaccinated as targeted in national plan (by gender) | Value | 0.00 | 38.85 | 54.00 |
Date | June 1, 2021 | November 13, 2023 | March 31, 2025 | |
Comment |
NPHI operationalized | Value | No | No | Yes |
Date | November 2, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Female population vaccinated | Value | 0.00 | 53.40 | 50.00 |
Date | June 1, 2021 | November 13, 2023 | March 31, 2025 | |
Comment |
Male population vaccinated | Value | 0.00 | 46.60 | 50.00 |
Date | June 1, 2021 | November 13, 2023 | March 31, 2025 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of health workers trained in all capacity building modules for GBV health sector response | Value | 0.00 | 325.00 | 100.00 |
Date | September 25, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of healthcare workers trained on IPC | Value | 0.00 | 1707.00 | 945.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of designated blood transfusion centers (regional and satellite centers) with TTI diagnostic equipment and reagents | Value | 0.00 | 100.00 | 80.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of designated referral facilities renovated/constructed | Value | 0.00 | 1.00 | 2.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of covid-19 designated health facilities and labs with waste treatment equipment installed and functional | Value | 0.00 | 0.00 | 12.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of designated facilities that have functional handheld infrared thermometers to screen COVID-19 as per MOH guidelines | Value | 0.00 | 100.00 | 80.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of Health Sector Action Plans for GBV developed as informed by results of quality assurance tool | Value | 0.00 | 0.00 | 10.00 |
Date | September 25, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of lab staff trained on sample collection and packaging | Value | 0.00 | 552.00 | 500.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of KNBTS satellite centers linked to and using blood service information system | Value | 0.00 | 70.00 | 80.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of incinerator operators trained | Value | 0.00 | 0.00 | 1778.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of testing equipment supplied to testing facilities | Value | 0.00 | 17.00 | 17.00 |
Date | September 25, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Assessment conducted to identify behavioral and socio-cultural risk factors for COVID-19 | Value | No | Yes | Yes |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of county vaccine stores equipped with a cold room | Value | 0.00 | 0.00 | 25.00 |
Date | June 1, 2021 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of vulnerable and marginalized communities reached in their indigenous language | Value | 0.00 | 79.00 | 80.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of complaints to the GRM satisfactorily addressed within 4 weeks of initial complaint being recorded. | Value | 0.00 | 100.00 | 80.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Number of surge capacity health workers contracted and deployed for case management | Value | 0.00 | 477.00 | 300.00 |
Date | April 13, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
Percentage of beneficiaries reporting community engagement and outreach meet their needs | Value | 0.00 | 87.00 | 80.00 |
Date | September 25, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |
NPHI strategic plan developed | Value | No | No | Yes |
Date | September 25, 2020 | November 13, 2023 | March 31, 2025 | |
Comment |